July 3rd 2024
Clinical trial for BI 3034701 is expected to evaluate the safety, tolerability, and pharmacokinetics in healthy men and overweight or obese individuals aged 18-55 years old.
Achieving Successful Decentralized Trials by Leveraging RBQM and Centralized Monitoring Oversight
April 7th 2022As market factors drive the rapid growth of decentralized clinical trials, organizations should embrace risk-based quality management to evaluate the new dimensions of risk and ensure effective oversight of disparate data sources, writes John Hall.
Opportunities for Improving Clinical Decisions with Patient Centric Remote Blood Sampling Approaches
September 22nd 2021This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.